神经性厌食症中低血糖的驱动因素:临床严重程度,BMI和疾病持续时间
Alfredo Pulini1,2, Odile Viltart3, Mathilde Septier2
1Université Paris Cité Faculté de Santé, France.
概括
疾病的持续时间,而不是BMI,显著影响到精神性厌食症 (AN) 患者的血糖模式. 持续的葡萄糖监测 (CGM) 揭示了这些代谢变化,为疾病严重程度和潜在的适应提供了见解.
科学领域:
- 内分泌学 在内分泌学.
- 代谢障碍 代谢障碍 代谢障碍
- 营养精神病学 营养精神病学
背景情况:
- 神经性厌食症 (AN) 是一种严重的饮食障碍,患病率和死亡率很高.
- 低血糖是AN严重程度的一个关键指标,传统上通过单次血液检测来评估.
- 持续血糖监测 (CGM) 提供了对血糖波动的更详细的了解.
研究的目的:
- 用CGM来表征女性门诊AN患者的血糖模式.
- 调查代谢严重程度 (BMI),临床严重程度 (EDI-2分数) 和疾病持续时间对血糖概况的影响.
主要方法:
- 一项涉及304名女性门诊患者的横截面研究,其中包括具有限制性类型的AN.
- 参与者在他们的自然环境中接受了为期5天的CGM.
- 对血糖生物标志物的分析,包括低血糖在曲线下的面积 (AUC),平均值,最低葡萄糖和变化系数.
主要成果:
- 在血糖生物标志物和身体质量指数 (BMI) 之间没有发现显著的相关性.
- 疾病持续时间与平均和最低葡萄糖水平 (r=0.26,r=0.23) 和低血糖AUC (r=-0.25) 有显著的关联.
- 这些发现具有统计学意义 (p < 0.001).
结论:
- 疾病持续时间,而不是BMI,是AN患者血糖概况的重要决定因素.
- CGM是了解AN中的代谢适应和临床意义的宝贵工具.
- 需要进一步的研究来探索这些血糖适应.
相关概念视频
Anorexia Nervosa
865
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
865
Hypoglycemia and Glucagon
772
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
772
Bulimia Nervosa
641
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
641
Insulin: Dosing Regimen and Adverse Effects
656
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
656
Binge Eating Disorders
402
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
402
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K


